| Newsletter | Subject |
| Vol. 7 No. 10 |
Does the end justify the means?
|
| Vol. 7 No. 9 |
Communications
|
| Vol. 7 No. 8 |
Presidents' Day and Washington's Birthday: Which is Which?
|
| Vol. 7 No. 7 |
Valentine's Day! Who/What Are We Celebrating?
|
| Vol. 7 No. 6 |
Quality Improvement in Pharmaceutical Compounding
|
| Vol. 7 No. 5 |
Thinking About Tomorrow!
|
| Vol. 7 No. 4 |
Working Together
|
| Vol. 7 No. 3 |
Confusing Rules with Principles
|
| Vol. 7 No. 2 |
Cowboy Ethics Revisited: What Has Happened to Our Culture?
|
| Vol. 7 No. 1 |
Happy New Year!
|
| Vol. 6 No. 50 |
Merry Christmas!
|
| Vol. 6 No. 49 |
A Profession or a Job
|
| Vol. 6 No. 48 |
The U.S. Healthcare System is NOT “Broken”!
|
| Vol. 6 No. 47 |
Thanksgiving
|
| Vol. 6 No. 46 |
Media and Political Manipulation: Who is Manipulating Whom?
|
| Vol. 6 No. 45 |
Tamiflu Suspension Revisited
|
| Vol. 6 No. 44 |
Are these still in effect? Part 2
|
| Vol. 6 No. 43 |
Are these still in effect? Part 1
|
| Vol. 6 No. 42 |
2009 NCPA Program Sessions on Compounding in New Orleans
|
| Vol. 6 No. 41 |
Thyroid and Tamiflu!
|
| Vol. 6 No. 40 |
The 2009 H1N1 Flu, the Media, and the RxTriad
|
| Vol. 6 No. 39 |
Aging
|
| Vol. 6 No. 38 |
Melamine is Back!
|
| Vol. 6 No. 37 |
Drug Product Shortages: Opportunities for Compounding
|
| Vol. 6 No. 36 |
Labor Day: How it Came About; What it Means
|
| Vol. 6 No. 35 |
False Economy? Think before you act!
|
| Vol. 6 No. 34 |
Privacy vs Need to Know: How far do we put our trust?
|
| Vol. 6 No. 33 |
Basis for decisions: Documentation and/or judgment
|
| Vol. 6 No. 32 |
Snippets!
|
| Vol. 6 No. 31 |
Let's make a deal!
|
| Vol. 6 No. 30 |
Believe it or not!
|
| Vol. 6 No. 29 |
The Age of Communications for the Ages
|
| Vol. 6 No. 28 |
Florida Pharmacists Association Annual Meeting 2009
|
| Vol. 6 No. 27 |
We're All In This Together!
|
| Vol. 6 No. 26 |
Compounders on Capitol Hill a Great Success
|
| Vol. 6 No. 25 |
Trends in Drug Shortages; Opportunities for Compounding, Part 2
|
| Vol. 6 No. 24 |
Trends in Drug Shortages; Opportunities for Compounding, Part 1
|
| Vol. 6 No. 23 |
Quality Assurance of Parenteral Preparations
|
| Vol. 6 No. 22 |
Automatons
|
| Vol. 6 No. 21 |
Wyeth is at it again! Women are being cheating of estriol and Medicaid of millions of dollars
|
| Vol. 6 No. 20 |
Quality Assurance of Special Hard Gelatin Capsules
|
| Vol. 6 No. 19 |
Compounding Around the World
|
| Vol. 6 No. 18 |
Quality Assurance of Suppositories, Troches, Lollipops, and Sticks
|
| Vol. 6 No. 17 |
Quality Control, Quality Assurance and Quality Improvement-What is the Difference and Why Should You Care?
|
| Vol. 6 No. 16 |
Going backwards?
|
| Vol. 6 No. 15 |
Quality Assurance of Ointments, Creams, and Gels
|
| Vol. 6 No. 14 |
Quality Assurance of Oral and Topical Liquids
|
| Vol. 6 No. 13 |
Quality Assurance of Powder-Filled, Hard-Gelatin Capsules
|
| Vol. 6 No. 12 |
Is it realistic to think that through the government…
|
| Vol. 6 No. 11 |
INFARMA 2009
|
| Vol. 6 No. 10 |
Life, Liberty, and the Pursuit of Happiness OR ...
|
| Vol. 6 No. 9 |
States of Matter; States of States!
|
| Vol. 6 No. 8 |
Back to the Basics!
|
| Vol. 6 No. 7 |
My Two Cents!
|
| Vol. 6 No. 6 |
Discussion of Data and Demeanor
|
| Vol. 6 No. 5 |
Insurance Discrimination! Time for a Class Action xyzxyz?
|
| Vol. 6 No. 4 |
Things are Changing!
|
| Vol. 6 No. 3 |
Change!
|
| Vol. 6 No. 2 |
The Blind Leading the Blind; Let’s Open Their Eyes
|
| Vol. 6 No. 1 |
Resolutions Anyone?
|
| Vol. 5 No. 49 |
It's Hard to Believe!
|
| Vol. 5 No. 48 |
Economic Correction May Be What We Need
|
| Vol. 5 No. 47 |
Lack of Discipline or Circumstances: What is the Cause?
|
| Vol. 5 No. 46 |
Thanksgiving
|
| Vol. 5 No. 45 |
Isn't it interesting that...
|
| Vol. 5 No. 44 |
A lot of "bellyaching" going on this past year!
|
| Vol. 5 No. 43 |
“New Drug,” Labeling, and Label Responsibility
|
| Vol. 5 No. 42 |
Stress
|
| Vol. 5 No. 41 |
Should Black-Box Warnings be Dispensed with Commercial Prescriptions?
|
| Vol. 5 No. 40 |
Are we there yet?
|
| Vol. 5 No. 39 |
Misdirection
|
| Vol. 5 No. 38 |
Compounding Around the World!
|
| Vol. 5 No. 37 |
"Reporters" or "Political Activists"
|
| Vol. 5 No. 36 |
8-Tracks for Sale
|
| Vol. 5 No. 35 |
The Politics of Change
|
| Vol. 5 No. 34 |
AMA Action on Non-FDA-Approved Compounded Medications
|
| Vol. 5 No. 33 |
Dumb, Dumber, and Dumbest!
|
| Vol. 5 No. 32 |
Healthcare Reform: Different Things to Different People
|
| Vol. 5 No. 31 |
Cephalosporin Extra-Label Use to be Banned
|
| Vol. 5 No. 30 |
Standardized Formulas
|
| Vol. 5 No. 29 |
"New Drug", "Labeling" and the Midland Decision
|
| Vol. 5 No. 28 |
“Compounding Around the World”
|
| Vol. 5 No. 27 |
Who Owns the United States?
|
| Vol. 5 No. 26 |
Two Little Words
|
| Vol. 5 No. 25 |
Should the Government and Insurance Companies Pay for "Lifestyle" Drugs?
|
| Vol. 5 No. 24 |
DTC Advertising!
|
| Vol. 5 No. 23 |
IJPC-APhA Strategic Alliance
|
| Vol. 5 No. 22 |
It's Here—USP Chapter <797> is Official
|
| Vol. 5 No. 21 |
Lookin’, Learnin’, and Lobbyin’ at CCH 2008
|
| Vol. 5 No. 20 |
Made in the USA
|
| Vol. 5 No. 19 |
Twelve "Whereas's" and 1 "Be it Resolved"!
|
| Vol. 5 No. 18 |
Have We Learned Our Lesson Yet?
|
| Vol. 5 No. 17 |
USP Chapter <797> Question of the Week
|
| Vol. 5 No. 16 |
USP Chapter <797> Frequently Asked Questions
|
| Vol. 5 No. 15 |
No recourse for patients and consumers!
|
| Vol. 5 No. 14 |
USP Chapter <797> Workshop #1
|
| Vol. 5 No. 13 |
Examinations for Students on Rotations?
|
| Vol. 5 No. 12 |
FDA Losing Credibility
|
| Vol. 5 No. 11 |
My Drug Problem (Anonymous Submission)
|
| Vol. 5 No. 10 |
Who's running the country?
|
| Vol. 5 No. 9 |
Change: One of the constants of the universe!
|
| Vol. 5 No. 8 |
Ethiopia Project
|
| Vol. 5 No. 7 |
Double Standards
|
| Vol. 5 No. 6 |
Eleven Rules of Life
|
| Vol. 5 No. 5 |
Opinions and Convictions: Who are you?
|
| Vol. 5 No. 4 |
FDA, Wyeth, and Global Harmonization
|
| Vol. 5 No. 3 |
Educate Your Patients about “Unapproved Drugs"
|
| Vol. 5 No. 2 |
Déjà vu all over again!
|
| Vol. 5 No. 1 |
A New Year with Opportunities and Challenges
|
| Vol. 4 No. 51 |
Who do you want to be today? Makeovers!
|
| Vol. 4 No. 50 |
Avastin: Packaging, Repackaging, or Prepackaging?
|
| Vol. 4 No. 49 |
Musings on the Length of Pharmacy Education
|
| Vol. 4 No. 48 |
Revised USP Chapter <797>...Now Available!
|
| Vol. 4 No. 47 |
Am I Missing Something Here!
|
| Vol. 4 No. 46 |
Avastin, Genentech, and Particulate Matter
|
| Vol. 4 No. 45 |
Politics and Truth: An Emulsion or Solution?
|
| Vol. 4 No. 44 |
Avastin Update
|
| Vol. 4 No. 43 |
12th Spanish Congress of Compounding Pharmacy
|
| Vol. 4 No. 42 |
Incredible!!!!
|
| Vol. 4 No. 41 |
HEADLINE: Prescription Drugs Unavailable!
|
| Vol. 4 No. 40 |
IJPC-What it is!
|
| Vol. 4 No. 39 |
Health Insurance: Who should pay?
|
| Vol. 4 No. 38 |
Discrimination Towards Patients by Insurance Companies!
|
| Vol. 4 No. 37 |
Professional Terminology
|
| Vol. 4 No. 36 |
Truth vs Opinion
|
| Vol. 4 No. 35 |
Truth, Justice, and the American Way!
|
| Vol. 4 No. 34 |
Decimal Points and Units
|
| Vol. 4 No. 33 |
Free Prescriptions-What's Wrong with this Picture?
|
| Vol. 4 No. 32 |
Looking At or Looking Up To!
|
| Vol. 4 No. 31 |
Adverse Event Reporting in Compounding
|
| Vol. 4 No. 30 |
Two Good Questions
|
| Vol. 4 No. 29 |
Multi-State Annual Pharmacy Association Meetings
|
| Vol. 4 No. 28 |
Best Ever IACP Compounders on Capitol Hill!
|
| Vol. 4 No. 27 |
The White Coats are Coming!
|
| Vol. 4 No. 26 |
Freedom!
|
| Vol. 4 No. 25 |
Off-Label Uses of Drugs
|
| Vol. 4 No. 24 |
Quality Assurance in Compounding, Part XII
|
| Vol. 4 No. 23 |
Quality Assurance in Compounding, Part XI
|
| Vol. 4 No. 22 |
Quality Assurance in Compounding, Part X
|
| Vol. 4 No. 21 |
Quality Assurance in Compounding, Part IX
|
| Vol. 4 No. 20 |
Quality Assurance in Compounding, Part VIII
|
| Vol. 4 No. 19 |
Quality Assurance in Compounding, Part VII
|
| Vol. 4 No. 18 |
Pharmaceuticals and the Internet
|
| Vol. 4 No. 17 |
Quality Assurance in Compounding, Part VI
|
| Vol. 4 No. 16 |
Quality Assurance in Compounding, Part V
|
| Vol. 4 No. 15 |
Quality Assurance in Compounding, Part IV
|
| Vol. 4 No. 14 |
Quality Assurance in Compounding, Part III
|
| Vol. 4 No. 13 |
The Shell Game
|
| Vol. 4 No. 12 |
Quality Assurance in Compounding, Part II
|
| Vol. 4 No. 11 |
Quality Assurance in Compounding, Part I
|
| Vol. 4 No. 10 |
Who's the Criminal?
|
| Vol. 4 No. 9 |
Sphere of Influence
|
| Vol. 4 No. 8 |
The International Journal of Pharmaceutical Compounding—More Than a Journal
|
| Vol. 4 No. 7 |
FDA is Generating Income and Patients Lose Again
|
| Vol. 4 No. 6 |
How do I Select a Good Compounding Pharmacy?
|
| Vol. 4 No. 5 |
It Just Doesn't Calculate!
|
| Vol. 4 No. 4 |
I Don't Really Care About Apathy.
|
| Vol. 4 No. 3 |
Misrepresentations!
|
| Vol. 4 No. 2 |
Here We Go Again!
|
| Vol. 4 No. 1 |
Overs!
|
| Vol. 3 No. 52 |
Change!
|
| Vol. 3 No. 51 |
Pharmacy Compounding Accreditation Board Surveyors Trained
|
| Vol. 3 No. 50 |
The FDA vs the Federal Government
|
| Vol. 3 No. 49 |
Standard Operating Procedures, Part 2
|
| Vol. 3 No. 48 |
Standard Operating Procedures, Part 1
|
| Vol. 3 No. 47 |
The World's Largest College of Pharmacy
|
| Vol. 3 No. 46 |
Comments on the AMA Resolution
|
| Vol. 3 No. 45 |
Third-Party Payers Arbitrarily Discriminate
|
| Vol. 3 No. 44 |
Exhibit Halls at Meetings Reflect Changes
|
| Vol. 3 No. 43 |
Election time again!
|
| Vol. 3 No. 42 |
National Community Pharmacy Association (NCPA), Las Vegas, and Compounding
|
| Vol. 3 No. 41 |
Flak Jacket Not Required
|
| Vol. 3 No. 40 |
The Problem! Politicians and/or Bureaucrats?
|
| Vol. 3 No. 39 |
Quality Cannot be Tested into a Preparation, but, How Much is Enough?
|
| Vol. 3 No. 38 |
Compounding with Commercial Drugs Can Cause Errors!
|
| Vol. 3 No. 37 |
Big PHARMA and Misinformation!
|
| Vol. 3 No. 36 |
Why isn't everyone responsible?
|
| Vol. 3 No. 35 |
Federation of International Pharmacists (FIP) and the International Society of Pharmacy Compounding (ISPhC) Meetings in Brazil
|
| Vol. 3 No. 34 |
Drugmakers: Optimized for Failure?
|
| Vol. 3 No. 33 |
Second Pharmaceutical Compounding Quality Assurance Seminar
|
| Vol. 3 No. 32 |
Whatever Happened to Competition?
|
| Vol. 3 No. 31 |
Brand-Name Drug Companies Pay to Keep Generics Off the Market
|
| Vol. 3 No. 30 |
I Can't Believe It! Shake Well!
|
| Vol. 3 No. 29 |
Majority Suffers Because of the Minority!
|
| Vol. 3 No. 28 |
Personalized Medicine - Today!
|
| Vol. 3 No. 27 |
Support your pharmacy organizations!
|
| Vol. 3 No. 26 |
Headlines! Headlines! Headlines!
|
| Vol. 3 No. 25 |
Wyeth's FDA Warning letter of May 8, 2006; Part II
|
| Vol. 3 No. 24 |
Wyeth's FDA Warning letter of May 8, 2006; Part I
|
| Vol. 3 No. 23 |
AMA Resolution on Non-FDA-Approved Compounded Medications
|
| Vol. 3 No. 22 |
Pharmacy Compounding in Barcelona
|
| Vol. 3 No. 21 |
The Wyeth Petition, Part III: Are Today's Conjugated Estrogens "New Drugs"?
|
| Vol. 3 No. 20 |
Incomplete Labeling for Tacrolimus: Who is to Blame?
|
| Vol. 3 No. 19 |
The Wyeth Petition, Part II: It's Irrational!
|
| Vol. 3 No. 18 |
The Wyeth Petition, Part I: Is it Profits or Patients?
|
| Vol. 3 No. 17 |
Syringes must be used with care!
|
| Vol. 3 No. 16 |
Learning vs Education
|
| Vol. 3 No. 15 |
Kudos to the State of Mississippi
|
| Vol. 3 No. 14 |
First Pharmaceutical Compounding Quality Assurance Seminar
|
| Vol. 3 No. 13 |
Pharmacy Practice in France: Will it happen here in the US?
|
| Vol. 3 No. 12 |
European Association of Hospital Pharmacists in Geneva, Switzerland
|
| Vol. 3 No. 11 |
New Technology and Quality Control: Something New is Coming to Town
|
| Vol. 3 No. 10 |
I Don't Understand Why...
|
| Vol. 3 No. 9 |
Pharmacy Organizations: Do they Support You or Themselves?
|
| Vol. 3 No. 8 |
Patient Care Conflicts With Regulations, Laws, and Standards; AND Why do Insurance Companies Discriminate?
|
| Vol. 3 No. 7 |
Keep your paper copies!
|
| Vol. 3 No. 6 |
Kudos to IACP and the New Labeling Guidelines
|
| Vol. 3 No. 5 |
Corporate Greed!
|
| Vol. 3 No. 4 |
Talking to a Machine!
|
| Vol. 3 No. 3 |
"Specials" are not "Sale" Items in UK Pharmacies, Part II
|
| Vol. 3 No. 2 |
“Specials” are not “Sale” Items in UK Pharmacies, Part 1
|
| Vol. 3 No. 1 |
Where are the "statesmen"?
|
| Vol. 2 No. 50 |
Happy New Year
|
| Vol. 2 No. 49 |
Merry Christmas!
|
| Vol. 2 No. 48 |
Another Great Idea Gone Bad
|
| Vol. 2 No. 47 |
FDA and HHS National Leaders Support Individualized Medications!
|
| Vol. 2 No. 46 |
Orphan Drugs: Part II
|
| Vol. 2 No. 45 |
Orphan Drugs: Part I
|
| Vol. 2 No. 44 |
Acacia is Not Just Used in Drugs
|
| Vol. 2 No. 43 |
Unapproved Drugs, What's the big deal?
|
| Vol. 2 No. 42 |
Commercially Manufactured Bioidentical Hormones
|
| Vol. 2 No. 41 |
Chasing Rainbows? Part II
|
| Vol. 2 No. 40 |
Chasing Rainbows? Part I
|
| Vol. 2 No. 39 |
How do you keep up with pharmacy information?
|
| Vol. 2 No. 38 |
Overdosing the American Public? Compounding to the Rescue!
|
| Vol. 2 No. 37 |
Afraid to take responsibility?
|
| Vol. 2 No. 36 |
The FDA, Parenteral Drug Association (PDA) and Compounding for Clinical Studies
|
| Vol. 2 No. 35 |
Is "pharmacy" still a science-based profession?
|
| Vol. 2 No. 34 |
Kudos to the IJPC CNL and its' Moderator
|
| Vol. 2 No. 33 |
Priorities: First Three, Then Me!
|
| Vol. 2 No. 32 |
ACPE Requests Curriculum Content Input: Practicing Pharmacists Should Be Involved In Establishing Accreditation and Curriculum Standards, Part III
|
| Vol. 2 No. 31 |
ACPE Requests Curriculum Content Input: Practicing Pharmacists Should Be Involved In Establishing Accreditation and Curriculum Standards, Part II
|
| Vol. 2 No. 30 |
ACPE Requests Curriculum Content Input: Practicing Pharmacists Should Be Involved In Establishing Accreditation and Curriculum Standards, Part I
|
| Vol. 2 No. 29 |
The Seven Categories of Compounding
|
| Vol. 2 No. 28 |
The Impending Health Care System Crisis and Pharmaceuticals
|
| Vol. 2 No. 27 |
Beyond-Use Dates
|
| Vol. 2 No. 26 |
First Meeting of the USP Compounding Committees in the 2005-2010 Cycle
|
| Vol. 2 No. 25 |
Contemporary Topics in Pharmaceutical Compounding
|
| Vol. 2 No. 24 |
Freedom Celebration (including the freedom to compound)
|
| Vol. 2 No. 23 |
To Split or Not to Split-That is the Question: and the Answer is NO!!!!
|
| Vol. 2 No. 22 |
The New USP-Pharmacists' Pharmacopeia
|
| Vol. 2 No. 21 |
IACP-Compounders on Capitol Hill Meeting
|
| Vol. 2 No. 20 |
Should Pharmacists Handle Dangerous Chemicals
|
| Vol. 2 No. 19 |
USP-Part 6: General Questions and Comments
|
| Vol. 2 No. 18 |
USP-Part 5: Resolutions of the 2005 USP Convention, Concluded
|
| Vol. 2 No. 17 |
USP-Part 4: Resolutions of the 2005 USP Convention, Continued
|
| Vol. 2 No. 16 |
USP-Part 3: Resolutions of the 2005 USP Convention
|
| Vol. 2 No. 15 |
USP-Part 2: USP Expert Committee Procedures
|
| Vol. 2 No. 14 |
USP-Part 1: USP Compounding Pharmacy Expert Committees 2005-2010
|
| Vol. 2 No. 13 |
Four White Papers
|
| Vol. 2 No. 12 |
Find Out What You Don't Know
|
| Vol. 2 No. 11 |
The USP and its Support of Pharmaceutical Compounding
|
| Vol. 2 No. 10 |
Compounding “Unapproved New Drugs”
|
| Vol. 2 No. 9 |
Compounding For Office Use-Some Observations and Comments
|
| Vol. 2 No. 8 |
Affectors of Laboratory Results: Part VIII
|
| Vol. 2 No. 7 |
Affectors of Laboratory Results: Part VII
|
| Vol. 2 No. 6 |
Affectors of Laboratory Results: Part VI
|
| Vol. 2 No. 5 |
Affectors of Laboratory Results: Part V
|
| Vol. 2 No. 4 |
Affectors of Laboratory Results: Part IV
|
| Vol. 2 No. 3 |
Affectors of Laboratory Results: Part III
|
| Vol. 2 No. 2 |
Affectors of Laboratory Results: Part II
|
| Vol. 2 No. 1 |
Affectors of Laboratory Results: Part I
|
| Vol. 1 No. 6 |
The Science and Technology of Pharmaceutical Compounding...Worldwide (ISPhC)
|
| Vol. 1 No. 5 |
Systemic Anti-Inflammatories and Cardiac Problems
|
| Vol. 1 No. 4.1 |
Proposed Revisions to USP Chapter <797> Pharmaceutical Compounding - Sterile Preparations
|
| Vol. 1 No. 4 |
What a year for IJPC and compounding!
|
| Vol. 1 No. 3 |
Therapeutic Blood Levels
|
| Vol. 1 No. 2 |
USP-NF Grade Ingredients
|
| Vol. 1 No. 1 |
Introducing CompoundingToday.com
|
